Hot Flashes & Night Sweats in Menopause & Perimenopause

Vasomotor symptoms (VMS) are the medical name for hot flashes and night sweats. They are the most-studied menopause symptom and, for many women, the most disruptive.

What's happening in your body

Estrogen helps keep the brain's thermoregulatory center — a small region of the hypothalamus — tuned to a wide "comfort" temperature window. As estradiol falls and fluctuates during perimenopause, that window narrows. Tiny shifts in core body temperature that would normally go unnoticed now cross a threshold, and the brain reacts as if you are dangerously overheating [1][3].

The response is fast and physical: blood vessels near the skin dilate, heart rate rises, you flush, and you sweat. When it resolves you can be left cold and shaky. The mechanism is now understood to run through KNDy neurons in the hypothalamus — the discovery that opened the door to the newer non-hormonal NK3-receptor drugs [3].

Night sweats are the same physiology, at night. They fragment sleep, and fragmented sleep amplifies almost every other menopause symptom — mood, weight, brain fog, energy. That is why treating VMS often improves problems that seem unrelated.

The Study of Women's Health Across the Nation (SWAN) tracked VMS in over 1,400 women and found the median total duration is 7.4 years, with symptoms often persisting more than 4 years after the final menstrual period. Duration is not the same for everyone — Black women in the study experienced VMS for a median of 10.1 years, white women 6.5 years [2]. Being told "just wait it out" underestimates the timeline for most women.

How common is this?

What it feels like

• A wave of heat that rises up through the chest, neck, and face — arriving in seconds, unrelated to the room temperature.
• Waking at 2–4 a.m. drenched, throwing off the blanket, then getting cold as the sweat cools.
• A racing heartbeat or a wash of anxiety just before the flush — often mistaken for a panic attack.
• Triggers that never used to matter: red wine, spicy food, a warm room, stress, tight clothing.

What helps

Lifestyle & environment

• Layer clothing in breathable fibers (cotton, linen, merino) so you can shed a layer at the first cue.
• Keep the bedroom cool (60–67°F is the range the Sleep Foundation cites for adult sleep) and use moisture-wicking bedding [4].
• Track triggers for two weeks — alcohol, caffeine after noon, spicy food, and stress are the most reported.
• Paced breathing, cognitive behavioral therapy for VMS, and clinical hypnosis have evidence for symptom reduction; they are not as effective as hormone therapy but are options when hormones are declined or contraindicated [1].

Treatments your provider may discuss

Hormone therapy — most often systemic estradiol paired with progesterone for women with a uterus — is described by The Menopause Society and ACOG as the most effective treatment currently available for moderate-to-severe vasomotor symptoms in appropriately selected patients. Whether it is right for any individual is a clinical decision your provider makes with you, weighing symptom burden, age, time since menopause, and personal medical history.

For women who cannot or prefer not to take hormones, several non-hormonal prescription options exist. Low-dose paroxetine is the only FDA-approved non-hormonal drug specifically for VMS. Fezolinetant is a newer NK3-receptor antagonist approved in 2023 that works directly on the hypothalamic pathway. Gabapentin and oxybutynin are also used off-label with evidence behind them [1][3]. Each has its own side-effect profile — this is a conversation to have with a licensed provider, not a self-selected choice.

Educational information only. Prescription decisions are made by a licensed provider based on your individual medical history.

When to see a provider

• VMS are disrupting your sleep, work, or relationships — that is a clinical threshold, not weakness.
• New palpitations that persist outside a hot flash, or come with chest pain, shortness of breath, or fainting — those need urgent evaluation, not menopause reassurance.
• Sudden onset before age 40 — this can be premature ovarian insufficiency and warrants a workup.

FAQ

Keep reading

Sources

1. The 2022 Hormone Therapy Position Statement — The Menopause Society. www.menopause.org
2. Duration of menopausal vasomotor symptoms over the menopause transition (SWAN) — JAMA Internal Medicine — Avis et al., 2015. jamanetwork.com/journals/jamainternalmedicine/fullarticle/2110996
3. Neurokinin-3 receptor antagonism and the KNDy pathway — NEJM / Fezolinetant SKYLIGHT trials. www.nejm.org
4. Bedroom temperature and sleep — National Sleep Foundation. www.thensf.org/what-is-the-best-temperature-for-sleep

This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Reviewed by the Kindr Health medical team · Last reviewed 2026-07-15.